MTOR and metabolic dysfunction-associated steatohepatitis: To compare the results of mouse models and humans and determine the differences in the mechanism of tumor development with NASH and virus infection, we also assessed the state of mTOR activation in HCCs of patients with metabolic syndrome and NASH as well as examples associated with hepatitis virus infection.